BEAVERTON, Ore., Sept. 19 /PRNewswire/ -- Epitope, Inc. (Nasdaq: EPTO) today announced that Charles E. Bergeron has been named as Chief Financial Officer for the Medical Products Group. Mr. Bergeron assumes these responsibilities in addition to his current position of Vice President of Operations for the Medical Products Group. This move is being made in anticipation of the spin-off of Agritope, the agricultural products group of Epitope. Gilbert Miller will remain as CFO for Epitope until the spin-off when he will assume the responsibilities of CFO for Agritope. "This move will help the medical products group through the transition as a stand-alone company and free up Mr. Miller's time to focus on the work associated with completing the spin-off of Agritope," said W. Charles Armstrong, president and chief executive officer. "Mr. Bergeron brings substantial experience to this position." Prior to joining Epitope in 1992 as President/CEO of Agrimax, Mr. Bergeron was the Senior Vice President, Finance at Freightliner from 1978 to 1992. Mr. Bergeron was also previously employed at IBM Corporation in sales, systems engineering and in finance positions prior to being employed at Freightliner. Mr. Bergeron has a Bachelor of Science in Management Engineering and a Masters of Science in Management Science from Rensseleaer Polytechnic Institute. He also earned an MBA from Columbia University Graduate School of Business. Epitope, Inc. is a biotechnology company that develops and markets medical diagnostic products. Its Agritope, Inc. subsidiary specializes in the development of new fruit and vegetable plant varieties.
Source: EPITOPE Inc.
Content of this page is copyright and reprinted here for educational and historical information.